The presence of MF-1 fibrosis, CALR mutation, and t(15;17)-driven NF1::SCAMP5 fusion may represent an atypical molecular–pathological profile warranting reclassification as “provisional MPN with unique genetic features” until further cases are reported. The gene discussed is NF1; the disease is myeloproliferative neoplasm.